UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2015-12, Vol.314 (23), p.2535

2015

Volltextzugriff (PDF)

Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH

Journal of clinical oncology, 2014-03, Vol.32 (8), p.783-790

2014

Volltextzugriff (PDF)

Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study

Neuro-oncology (Charlottesville, Va.), 2015-05, Vol.17 (5), p.708-717

2015

Volltextzugriff (PDF)

Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme

Journal of clinical oncology, 2008-12, Vol.26 (34), p.5610-5617

2008

Volltextzugriff (PDF)

Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402

Journal of clinical oncology, 2006-06, Vol.24 (18), p.2707-2714

2006

Volltextzugriff (PDF)

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas

Neuro-oncology (Charlottesville, Va.), 2008-04, Vol.10 (2), p.162-170

2008

Volltextzugriff (PDF)

Phase II Trial of Tipifarnib in Patients With Recurrent Malignant Glioma Either Receiving or Not Receiving Enzyme-Inducing Antiepileptic Drugs: A North American Brain Tumor Consortium Study

Journal of clinical oncology, 2006-08, Vol.24 (22), p.3651-3656

2006

Volltextzugriff (PDF)

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)

Neuro-oncology (Charlottesville, Va.), 2009-12, Vol.11 (6), p.853-860

2009

Volltextzugriff (PDF)

Phase II Evaluation of Temozolomide and 13-cis-Retinoic Acid for the Treatment of Recurrent and Progressive Malignant Glioma: A North American Brain Tumor Consortium Study

Journal of clinical oncology, 2003-06, Vol.21 (12), p.2305-2311

2003

Volltextzugriff (PDF)

A Phase I Trial of Tipifarnib With Radiation Therapy, With and Without Temozolomide, for Patients With Newly Diagnosed Glioblastoma

International journal of radiation oncology, biology, physics, 2011-12, Vol.81 (5), p.1422-1427

2011

Volltextzugriff (PDF)

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2017-12, Vol.318 (23), p.2306

2017

Volltextzugriff (PDF)

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

The lancet oncology, 2017-10, Vol.18 (10), p.1373-1385

2017

Volltextzugriff (PDF)

Phase I Trial of Tipifarnib in Patients With Recurrent Malignant Glioma Taking Enzyme-Inducing Antiepileptic Drugs: A North American Brain Tumor Consortium Study

Journal of clinical oncology, 2005-09, Vol.23 (27), p.6647-6656

2005

Volltextzugriff (PDF)

Phase I Study of Temozolomide and Irinotecan for Recurrent Malignant Gliomas in Patients Receiving Enzyme-Inducing Antiepileptic Drugs: A North American Brain Tumor Consortium Study

Clinical cancer research, 2007-12, Vol.13 (23), p.7133-7138

2007

Volltextzugriff (PDF)

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma

Clinical cancer research, 2019-10, Vol.25 (19), p.5799-5807

2019

Volltextzugriff (PDF)

Adult Primary Peripheral PNET/Ewing's Sarcoma of the Cervical and Thoracic Spine

Anticancer research, 2019-08, Vol.39 (8), p.4463-4465

2019

Volltextzugriff (PDF)

Phase II study of neoadjuvant 1,3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: A north American brain tumor consortium trial

Cancer, 2004-04, Vol.100 (8), p.1712-1716

2004

Volltextzugriff (PDF)

Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study

Neuro-oncology (Charlottesville, Va.), 2004-01, Vol.6 (1), p.44-54

2004

Volltextzugriff (PDF)

Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study

Neuro-oncology (Charlottesville, Va.), 2004-01, Vol.6 (1), p.33-37

2004

Volltextzugriff (PDF)

Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma

Neuro-oncology (Charlottesville, Va.), 2015-03, Vol.17 (3), p.430-439

2015

Volltextzugriff (PDF)

Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma

Neuro-oncology (Charlottesville, Va.), 2015-02, Vol.17 (2), p.266-273

2015

Volltextzugriff (PDF)

Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme

Investigational new drugs, 2005-08, Vol.23 (4), p.357-361

2005

Volltextzugriff (PDF)

A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05)

Journal of neuro-oncology, 2009-01, Vol.91 (2), p.175-182

2009

Volltextzugriff (PDF)

A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study

Neuro-oncology (Charlottesville, Va.), 2006-04, Vol.8 (2), p.189

2006

Volltextzugriff (PDF)

1 – 25 von 143

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(118)

Publikationsform

Artikel
(143)

Sprache

Englisch
(143)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial

Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH

Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study

Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme

Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas

Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08

Phase II Trial of Tipifarnib in Patients With Recurrent Malignant Glioma Either Receiving or Not Receiving Enzyme-Inducing Antiepileptic Drugs: A North American Brain Tumor Consortium Study

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)

Phase II Evaluation of Temozolomide and 13-cis-Retinoic Acid for the Treatment of Recurrent and Progressive Malignant Glioma: A North American Brain Tumor Consortium Study

A Phase I Trial of Tipifarnib With Radiation Therapy, With and Without Temozolomide, for Patients With Newly Diagnosed Glioblastoma

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Phase I Trial of Tipifarnib in Patients With Recurrent Malignant Glioma Taking Enzyme-Inducing Antiepileptic Drugs: A North American Brain Tumor Consortium Study

Phase I Study of Temozolomide and Irinotecan for Recurrent Malignant Gliomas in Patients Receiving Enzyme-Inducing Antiepileptic Drugs: A North American Brain Tumor Consortium Study

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma

Adult Primary Peripheral PNET/Ewing's Sarcoma of the Cervical and Thoracic Spine

Phase II study of neoadjuvant 1,3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: A north American brain tumor consortium trial

Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study

Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study

Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma

Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma

Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme

A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05)

A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study

Aktive Filter

Suchergebnisse filtern